healthprotocol.wiki

Protocols Evidence Outcomes

abemaciclib-200mg-twice-daily

Outcomes

01
oncology-tumor-inflammation-score
1 evidence row
- gleason_2022_cohort_abemaciclib-phase2-trial-liposarcoma

Evidence

1rows

On this page

Permalink

/protocols/abemaciclib-200mg-twice-daily

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.